Marshall Wace, LLP Intra Cellular Therapies, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,160,973 shares of ITCI stock, worth $148 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,160,973
Previous 499,015 132.65%
Holding current value
$148 Million
Previous $34.2 Million 148.38%
% of portfolio
0.11%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $45 Million - $53.5 Million
661,958 Added 132.65%
1,160,973 $84.9 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $32.3 Million - $39.8 Million
499,015 New
499,015 $34.2 Million
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $867,072 - $1.38 Million
-18,699 Reduced 43.54%
24,249 $1.74 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $3.41 Million - $4.2 Million
-65,500 Reduced 60.4%
42,948 $2.24 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $5.93 Million - $7.21 Million
108,448 New
108,448 $6.87 Million
Q2 2022

Aug 15, 2022
SELL
$43.0 - $65.64 $108 Million - $165 Million
-2,519,764 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $5.09 Million - $8.16 Million
131,470 Added 5.5%
2,519,764 $154 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $3.26 Million - $4.95 Million
92,660 Added 4.04%
2,388,294 $125 Million
Q3 2021

Nov 15, 2021
SELL
$28.72 - $42.49 $13.7 Million - $20.2 Million
-475,670 Reduced 17.16%
2,295,634 $85.6 Million
Q2 2021

Aug 13, 2021
SELL
$29.3 - $44.5 $1.85 Million - $2.81 Million
-63,156 Reduced 2.23%
2,771,304 $113 Million
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $5.58 Million - $7.16 Million
-181,272 Reduced 6.01%
2,834,460 $96.2 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $78,305 - $108,098
3,355 Added 0.11%
3,015,732 $95.9 Million
Q3 2020

Nov 16, 2020
BUY
$17.61 - $31.86 $29.8 Million - $54 Million
1,694,447 Added 128.57%
3,012,377 $77.3 Million
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $9.09 Million - $16.9 Million
633,152 Added 92.46%
1,317,930 $33.8 Million
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $8.43 Million - $22.7 Million
684,778 New
684,778 $10.5 Million

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email